April 26, 2022
Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
April 6, 2022
Sema4 Achieves HITRUST CSF Certification
April 5, 2022
Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
March 16, 2022
Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved Communities
March 14, 2022
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
March 8, 2022
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
February 22, 2022
Sema4 to Report Fourth Quarter and Full Year 2021 Financial Results and Participate in Investor Conferences in March 2022
February 22, 2022
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
February 3, 2022
Sema4 to Participate at Two Upcoming Investor Conferences in February
February 1, 2022
Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities
Displaying 11 - 20 of 23